China Resources Boya Bio-pharmaceutical Group Co., Ltd.
300294.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.5B
Close$
$11.61
19.5% downside
Current Fair Value
19.5% downsideOvervalued by 19.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.50 Billion |
|---|---|
| Enterprise Value | $6.89 Billion |
| Dividend Yield | $0.22 (1.50%) |
| Earnings per Share | $0.22 |
| Beta | 0.42 |
| Outstanding Shares | 504,248,738 |
Return
| Return on Equity | -0.83% |
|---|---|
| Return on Assets | -0.74% |
| Return on Invested Capital | -1.70% |
Valuation & Multiples
| P/E Ratio | -115.8 |
|---|---|
| PEG | 153.22 |
| Price to Sales | 4.81 |
| Price to Book Ratio | 1.03 |
| Enterprise Value to Revenue | 4.07 |
| Enterprise Value to EBIT | -53.36 |
| Enterprise Value to Net Income | -113 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 22, 2026
EPS Estimate
$0.39
Average shareholder expectationRevenue Estimate
$322.43 M
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$319.11 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Resources Boya Bio-pharmaceutical Group Co., Ltd.
1,947 employees
CEO: Yuxuan Pan Established in 1993 and headquartered in Fuzhou, China, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (formerly Boya Bio-pharmaceutical Group Co., Ltd.) is a comprehensive pharmaceutical enterprise operating across China. The c...